Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: Mol Cancer Ther. 2010 Jun 1;9(6):1688–1696. doi: 10.1158/1535-7163.MCT-09-0919

Fig. 5. ARC synergizes with ABT-737 in inducing caspase-3 cleavage in human colon, liver and pancreatic cancer cells.

Fig. 5

A. SW480 and LIM1215 colon cancer cells were treated as indicated for 24 hrs and analyzed by immunoblotting. B. Huh-7 and HepG2 liver cancer cells were treated with ARC, ABT-737 and combination of ARC/ABT-737 as shown and immunoblotted for the proteins as indicated. C. Pancreatic cancer cells, HPAC were treated with ARC, ABT-737 or both and analyzed for the expression of Mcl-1, cleaved caspase-3 and β-actin by immunoblotting.